CAPRICOR THERAPEUTICS, INC. Financing Cash Flow
CAPRICOR THERAPEUTICS, INC. (CAPR) reported Financing Cash Flow of -$2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-14
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$4.24M, a 21770.39% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $1.47M, a 2820.64% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $248.82M, a 206.85% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $6.95K, a 99.99% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2025 was $248.89M, a 62.92% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2024 was $152.77M, a 497.23% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2023 was $25.58M, a 424.84% increase from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. net cash provided by (used in) financing activities for fiscal 2022 was $4.87M, a 75.90% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 9 month as first filed | Net Cash Provided by (Used in) Financing Activities 12 month | Net Cash Provided by (Used in) Financing Activities 71 month | Net Cash Provided by (Used in) Financing Activities 74 month | Net Cash Provided by (Used in) Financing Activities 77 month | Net Cash Provided by (Used in) Financing Activities 80 month | Net Cash Provided by (Used in) Financing Activities 83 month | Net Cash Provided by (Used in) Financing Activities 86 month | Net Cash Provided by (Used in) Financing Activities 89 month | Net Cash Provided by (Used in) Financing Activities 92 month | Net Cash Provided by (Used in) Financing Activities 95 month | Net Cash Provided by (Used in) Financing Activities 98 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$2.77M 10-Q · filed 2026-08-14 | $246.04M derived: sum of 3 quarters · filed 2026-08-14 | $246.05M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-13 | $250.29M derived: sum of 2 quarters · filed 2026-05-13 | $250.29M derived: sum of 3 quarters · filed 2026-05-13 | $250.31M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||
| 2025-12-31 | $248.82M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $248.82M derived: sum of 2 quarters · filed 2026-03-17 | $248.84M derived: sum of 3 quarters · filed 2026-08-14 | $248.89M 10-K · filed 2026-03-17 | |||||||||||
| 2025-09-30 | $6.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $26.53K derived: sum of 2 quarters · filed 2026-08-14 | $76.88K 10-Q · filed 2025-11-10 | $81.16M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||
| 2025-06-30 | $19.58K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $69.93K 10-Q · filed 2026-08-14 | $81.16M derived: sum of 3 quarters · filed 2026-08-14 | $148.48M derived: sum of 4 quarters · filed 2026-08-14 | |||||||||||
| 2025-03-31 | $50.35K 10-Q · filed 2026-05-13 | $81.14M derived: sum of 2 quarters · filed 2026-05-13 | $148.46M derived: sum of 3 quarters · filed 2026-05-13 | $150.53M derived: sum of 4 quarters · filed 2026-05-13 | |||||||||||
| 2024-12-31 | $81.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $148.41M derived: sum of 2 quarters · filed 2026-03-17 | $150.48M derived: sum of 3 quarters · filed 2026-03-17 | $152.77M 10-K · filed 2026-03-17 | |||||||||||
| 2024-09-30 | $67.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $69.39M derived: sum of 2 quarters · filed 2025-11-10 | $71.68M 10-Q · filed 2025-11-10 | $94.85M derived: sum of 4 quarters · filed 2025-11-10 | |||||||||||
| 2024-06-30 | $2.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $4.36M 10-Q · filed 2025-08-11 | $27.52M derived: sum of 3 quarters · filed 2025-08-11 | $27.75M derived: sum of 4 quarters · filed 2025-08-11 | |||||||||||
| 2024-03-31 | $2.29M 10-Q · filed 2025-05-14 | $25.46M derived: sum of 2 quarters · filed 2025-05-14 | $25.68M derived: sum of 3 quarters · filed 2025-05-14 | $27.87M derived: sum of 4 quarters · filed 2025-05-14 | |||||||||||
| 2023-12-31 | $23.17M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $23.39M derived: sum of 2 quarters · filed 2025-03-26 | $25.58M derived: sum of 3 quarters · filed 2025-03-26 | $25.58M 10-K · filed 2025-03-26 | |||||||||||
| 2023-09-30 | $221.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $2.41M derived: sum of 2 quarters · filed 2024-11-14 | $2.41M 10-Q · filed 2024-11-14 | $5.36M derived: sum of 4 quarters · filed 2024-11-14 | |||||||||||
| 2023-06-30 | $2.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $2.19M 10-Q · filed 2024-08-08 | $5.14M derived: sum of 3 quarters · filed 2024-08-08 | $7.02M derived: sum of 4 quarters · filed 2024-08-08 | |||||||||||
| 2023-03-31 | $3.90K 10-Q · filed 2024-05-14 | $2.95M derived: sum of 2 quarters · filed 2024-05-14 | $4.84M derived: sum of 3 quarters · filed 2024-05-14 | $4.85M derived: sum of 4 quarters · filed 2024-05-14 | |||||||||||
| 2022-12-31 | $2.95M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $4.83M derived: sum of 2 quarters · filed 2024-03-11 | $4.85M derived: sum of 3 quarters · filed 2024-03-11 | $4.87M 10-K · filed 2024-03-11 | |||||||||||
| 2022-09-30 | $1.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.90M derived: sum of 2 quarters · filed 2023-11-14 | $1.92M 10-Q · filed 2023-11-14 | $1.97M derived: sum of 4 quarters · filed 2023-11-14 | |||||||||||
| 2022-06-30 | $15.01K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $42.47K 10-Q · filed 2023-08-08 | $84.84K derived: sum of 3 quarters · filed 2023-08-08 | $6.65M derived: sum of 4 quarters · filed 2023-08-08 | |||||||||||
| 2022-03-31 | $27.46K 10-Q · filed 2023-05-12 | $69.83K derived: sum of 2 quarters · filed 2023-05-12 | $6.64M derived: sum of 3 quarters · filed 2023-05-12 | $7.67M derived: sum of 4 quarters · filed 2023-05-12 | |||||||||||
| 2021-12-31 | $42.37K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-17 | $6.61M derived: sum of 2 quarters · filed 2023-03-17 | $7.65M derived: sum of 3 quarters · filed 2023-03-17 | $20.23M 10-K · filed 2023-03-17 | |||||||||||
| 2021-09-30 | $6.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $7.60M derived: sum of 2 quarters · filed 2022-11-10 | $20.18M 10-Q · filed 2022-11-10 | $21.68M derived: sum of 4 quarters · filed 2022-11-10 | |||||||||||
| 2021-06-30 | $1.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $13.62M 10-Q · filed 2022-08-12 | $15.11M derived: sum of 3 quarters · filed 2022-08-12 | $17.29M derived: sum of 4 quarters · filed 2022-08-12 | |||||||||||
| 2021-03-31 | $12.58M 10-Q · filed 2022-05-11 | $14.08M derived: sum of 2 quarters · filed 2022-05-11 | $16.25M derived: sum of 3 quarters · filed 2022-05-11 | $41.41M derived: sum of 4 quarters · filed 2022-05-11 | |||||||||||
| 2020-12-31 | $1.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.67M derived: sum of 2 quarters · filed 2022-03-11 | $28.83M derived: sum of 3 quarters · filed 2022-03-11 | $33.38M 10-K · filed 2022-03-11 | |||||||||||
| 2020-09-30 | $2.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $27.34M derived: sum of 2 quarters · filed 2021-11-12 | $31.89M 10-Q · filed 2021-11-12 | $36.50M derived: sum of 4 quarters · filed 2021-11-12 | |||||||||||
| 2020-06-30 | $25.16M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $29.71M 10-Q · filed 2021-08-13 | $34.32M derived: sum of 3 quarters · filed 2021-08-13 | $36.91M derived: sum of 4 quarters · filed 2021-08-13 | |||||||||||
| 2020-03-31 | $4.55M 10-Q · filed 2021-05-14 | $9.16M derived: sum of 2 quarters · filed 2021-05-14 | $11.75M derived: sum of 3 quarters · filed 2021-05-14 | $12.29M derived: sum of 4 quarters · filed 2021-05-14 | |||||||||||
| 2019-12-31 | $4.61M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $7.20M derived: sum of 2 quarters · filed 2021-03-15 | $7.74M derived: sum of 3 quarters · filed 2021-03-15 | $9.18M 10-K · filed 2021-03-15 | |||||||||||
| 2019-09-30 | $2.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $3.13M derived: sum of 2 quarters · filed 2020-11-13 | $4.57M 10-Q · filed 2020-11-13 | $5.08M derived: sum of 4 quarters · filed 2020-11-13 | |||||||||||
| 2019-06-30 | $545.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $1.98M 10-Q · filed 2020-08-10 | $2.49M derived: sum of 3 quarters · filed 2020-08-10 | $3.54M derived: sum of 4 quarters · filed 2020-08-10 | |||||||||||
| 2019-03-31 | $1.43M 10-Q · filed 2020-05-15 | $1.95M derived: sum of 2 quarters · filed 2020-05-15 | $3.00M derived: sum of 3 quarters · filed 2020-05-15 | $5.77M derived: sum of 4 quarters · filed 2020-05-15 | |||||||||||
| 2018-12-31 | $512.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $1.57M derived: sum of 2 quarters · filed 2020-03-27 | $4.34M derived: sum of 3 quarters · filed 2020-03-27 | $6.85M 10-K · filed 2020-03-27 | |||||||||||
| 2018-09-30 | $1.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $3.83M derived: sum of 2 quarters · filed 2019-11-08 | $6.34M 10-Q · filed 2019-11-08 | $6.34M 10-Q · filed 2018-11-14 | $9.37M derived: sum of 4 quarters · filed 2019-11-08 | ||||||||||
| 2018-06-30 | $2.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $5.29M 10-Q · filed 2019-08-08 | $8.31M derived: sum of 3 quarters · filed 2019-08-08 | $12.94M derived: sum of 4 quarters · filed 2019-08-08 | |||||||||||
| 2018-03-31 | $2.51M 10-Q · filed 2019-05-14 | $5.54M derived: sum of 2 quarters · filed 2019-05-14 | $10.16M derived: sum of 3 quarters · filed 2019-05-14 | $14.09M derived: sum of 4 quarters · filed 2019-05-14 | |||||||||||
| 2017-12-31 | $3.03M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $7.65M derived: sum of 2 quarters · filed 2019-03-29 | $11.58M derived: sum of 3 quarters · filed 2019-03-29 | $11.58M 10-K · filed 2019-03-29 | |||||||||||
| 2017-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $8.55M derived: sum of 2 quarters · filed 2018-11-14 | $8.55M 10-Q · filed 2018-11-14 | $8.55M derived: sum of 4 quarters · filed 2018-11-14 | |||||||||||
| 2017-06-30 | $3.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $3.93M 10-Q · filed 2018-08-13 | $3.93M derived: sum of 3 quarters · filed 2018-08-13 | ||||||||||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-14 | $0.00 derived: sum of 2 quarters · filed 2018-05-14 | |||||||||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $18.63M 10-K · filed 2018-03-22 | |||||||||||||
| 2016-09-30 | $18.63M 10-Q · filed 2017-11-14 | ||||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $382.50K 10-Q · filed 2013-11-14 | $382.50K derived: sum of 4 quarters · filed 2013-11-14 | $35.79M 10-Q · filed 2013-11-14 | ||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $382.50K 10-Q · filed 2013-08-14 | $382.50K derived: sum of 3 quarters · filed 2013-08-14 | $382.50K derived: sum of 4 quarters · filed 2013-11-14 | $35.79M 10-Q · filed 2013-08-14 | ||||||||||
| 2013-03-31 | $382.50K 10-Q · filed 2013-06-21 | $382.50K derived: sum of 2 quarters · filed 2013-06-21 | $382.50K derived: sum of 3 quarters · filed 2013-11-14 | $1.58M derived: sum of 4 quarters · filed 2013-11-14 | $35.79M 10-Q · filed 2013-06-21 | ||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $0.00 derived: sum of 2 quarters · filed 2013-11-14 | $1.19M derived: sum of 3 quarters · filed 2013-11-14 | $1.19M 10-K · filed 2013-06-21 | $35.41M 10-K · filed 2013-06-21 | ||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-14 | $1.19M derived: sum of 2 quarters · filed 2013-11-14 | $1.19M 10-Q · filed 2013-11-14 | $1.20M derived: sum of 4 quarters · filed 2013-11-14 | $35.41M 10-Q · filed 2013-06-21 | ||||||||||
| 2012-06-30 | $1.19M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | $1.19M 10-Q · filed 2013-08-14 | $1.20M derived: sum of 3 quarters · filed 2013-08-14 | $1.20M derived: sum of 4 quarters · filed 2013-08-14 | $35.41M 10-Q/A · filed 2012-09-10 | ||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-06-21 | $2.50K derived: sum of 2 quarters · filed 2013-06-21 | $2.50K derived: sum of 3 quarters · filed 2013-06-21 | $2.31M derived: sum of 4 quarters · filed 2013-06-21 | $34.22M 10-Q · filed 2012-05-15 | ||||||||||
| 2011-12-31 | $2.50K derived: 10-K 12 month − 10-Q 9 month · filed 2013-06-21 | $2.50K derived: sum of 2 quarters · filed 2013-06-21 | $2.31M derived: sum of 3 quarters · filed 2013-06-21 | $2.31M 10-K · filed 2013-06-21 | $34.22M 10-K · filed 2012-04-02 | ||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-06-21 | $2.30M derived: sum of 2 quarters · filed 2013-06-21 | $2.31M 10-Q · filed 2013-06-21 | $2.31M derived: sum of 4 quarters · filed 2013-06-21 | $34.22M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $2.30M derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-10 | $2.31M 10-Q/A · filed 2012-09-10 | $2.31M derived: sum of 3 quarters · filed 2012-09-10 | $2.32M derived: sum of 4 quarters · filed 2012-09-10 | $34.22M 10-Q · filed 2011-08-15 | ||||||||||
| 2011-03-31 | $6.21K 10-Q · filed 2012-05-15 | $6.21K derived: sum of 2 quarters · filed 2012-05-15 | $12.41K derived: sum of 3 quarters · filed 2012-05-15 | ||||||||||||
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2012-04-02 | $6.21K derived: sum of 2 quarters · filed 2012-04-02 | $4.52M 10-K · filed 2012-04-02 | ||||||||||||
| 2010-09-30 | $6.21K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $4.52M 10-Q · filed 2011-11-14 | |||||||||||||
| 2010-06-30 | $4.52M 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |